Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 409 - 416 of 12093 results

Mintz Toronto Is in for the Long Haul as It Nears Two Years Proving Naysayers Wrong
January 17, 2025| News

Out with a Bang: President Biden Ends Final Week in Office with Three AI Actions — AI: The Washington Report
January 17, 2025| Article| Viewpoint

Tax-Exempt Bonds Axed in Menu of Options Floated by Ways and Means
January 17, 2025| News

Health Care Enforcement Trends & 2025 Outlook
January 17, 2025| Blog| Viewpoint

ETA Travel Requirement for Visitors to The United Kingdom
January 16, 2025| Resources| Viewpoint

EnforceMintz — Health Care Enforcement Trends & 2025 Outlook
January 16, 2025| Blog| Viewpoint

2025 FERC, DOE Outlook: Surging Demand Growth to Drive Power-Sector Agenda
January 16, 2025| News

EnforceMintz – DOJ Policy Developments in 2024 Seek to Motivate More Voluntary Self-Disclosures
January 16, 2025| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
